Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

786 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome.
Camacho-Hübner C, Rose S, Preece MA, Sleevi M, Storr HL, Miraki-Moud F, Minuto F, Frystyk J, Rogol A, Allan G, Sommer A, Savage MO. Camacho-Hübner C, et al. Among authors: allan g. J Clin Endocrinol Metab. 2006 Apr;91(4):1246-53. doi: 10.1210/jc.2005-1017. Epub 2006 Jan 10. J Clin Endocrinol Metab. 2006. PMID: 16403822 Clinical Trial.
Effects of combined recombinant insulin-like growth factor (IGF)-I and IGF binding protein-3 in type 2 diabetic patients on glycemic control and distribution of IGF-I and IGF-II among serum binding protein complexes.
Clemmons DR, Sleevi M, Allan G, Sommer A. Clemmons DR, et al. Among authors: allan g. J Clin Endocrinol Metab. 2007 Jul;92(7):2652-8. doi: 10.1210/jc.2006-2699. Epub 2007 Apr 10. J Clin Endocrinol Metab. 2007. PMID: 17426090 Clinical Trial.
786 results